UBS AM
TECX

UBS AM’s Tectonic Therapeutic TECX Stock Holding History

UBS AM’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Hold
382
– – ﹤0.01% 3217
2026
Q1 		$11.8K Buy
382
+209
+121% +$5.14K ﹤0.01% 3273
2025
Q4 		$3.61K Buy
+173
New +$3.21K ﹤0.01% 3038
2021
Q4 		– Sell
-2,674
Closed -$179K – 2909
2021
Q3 		$179K Hold
2,674
– – ﹤0.01% 2700
2021
Q2 		$285K Sell
2,674
-20,058
-88% -$2.38M ﹤0.01% 2654
2021
Q1 		$3.46M Buy
22,732
+81
+0.4% +$13.2K ﹤0.01% 1511
2020
Q4 		$3.79M Sell
22,651
-2,074
-8% -$369K ﹤0.01% 1407
2020
Q3 		$3.86M Buy
24,725
+476
+2% +$95.9K ﹤0.01% 1259
2020
Q2 		$5.08M Buy
24,249
+1,342
+6% +$277K ﹤0.01% 1109
2020
Q1 		$4.28M Buy
22,907
+8,687
+61% +$2.05M ﹤0.01% 1099
2019
Q4 		$3.43M Buy
14,220
+1,947
+16% +$375K ﹤0.01% 1358
2019
Q3 		$2.08M Hold
12,273
– – ﹤0.01% 1602
2019
Q2 		$2.39M Sell
12,273
-295
-2% -$63.6K ﹤0.01% 1495
2019
Q1 		$3.33M Sell
12,568
-227
-2% -$41.5K ﹤0.01% 1302
2018
Q4 		$2.56M Buy
12,795
+2,589
+25% +$789K ﹤0.01% 1329
2018
Q3 		$6.35M Buy
10,206
+456
+5% +$202K ﹤0.01% 1065
2018
Q2 		$3.34M Buy
+9,750
New +$3.52M ﹤0.01% 1299

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

UBS AM's TECX Position: Q2 2026 in Review

UBS AM held its Tectonic Therapeutic (TECX) position steady in Q2 2026 at 382 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3217.

UBS AM first reported a position in TECX in Q2 2018 and has held it in 17 quarters since. The position peaked at $6.35M in Q3 2018. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • UBS AM held 382 shares of Tectonic Therapeutic worth $13.1K as of Q2 2026.
  • UBS AM left its Tectonic Therapeutic share count unchanged in Q2 2026.
  • Tectonic Therapeutic made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3217 holding.
  • UBS AM first reported a position in Tectonic Therapeutic in Q2 2018 and has held it in 17 quarters since.
  • UBS AM's Tectonic Therapeutic position peaked at $6.35M in Q3 2018.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.